Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial.

MLA

Stauffer, Christopher S., et al. “Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial.” Frontiers in Psychiatry, vol. 13, Jan. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.3389/fpsyt.2021.804997.

APA

Stauffer, C. S., Samson, S., Hickok, A., Hoffman, W. F., & Batki, S. L. (2022). Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial. Frontiers in Psychiatry, 13, 1–11. https://doi.org/10.3389/fpsyt.2021.804997

Chicago

Stauffer, Christopher S., Salem Samson, Alex Hickok, William F. Hoffman, and Steven L. Batki. 2022. “Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial.” Frontiers in Psychiatry 13 (January): 1–11. doi:10.3389/fpsyt.2021.804997.